621
Views
58
CrossRef citations to date
0
Altmetric
Review

Saffron and its derivatives, crocin, crocetin and safranal: a patent review

, & ORCID Icon
Pages 147-165 | Received 13 May 2017, Accepted 12 Jul 2017, Published online: 18 Jul 2017

References

  • Mollazadeh H, Emami SA, Hosseinzadeh H Razi’s Al-Hawi and saffron (Crocus sativus): a review. Iran J Basic Med Sci. 2015;18:1153–1166.
  • Ríos JL, Recio MC, Giner RM, et al. An update review of saffron and its active constituents. Phytother Res. 1996;10:189–193.
  • Melnyk JP, Wang S, Marcone MF Chemical and biological properties of the world’s most expensive spice: saffron. Food Res Int. 2010;43:1981–1989.
  • Alavizadeh SH, Hosseinzadeh H Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol. 2014;64:65–80.
  • Shahi T, Assadpour E, Jafari SM Main chemical compounds and pharmacological activities of stigmas and tepals of ‘red gold’; saffron. Trends Food Sci Technol. 2016;58:69–78.
  • Hosseinzadeh H, Nassiri-Asl M. Avicenna’s (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytother Res. 2013;27:475–483.
  • Moshiri E, Basti AA, Noorbala -A-A, et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006;13:607–611.
  • Sánchez-Vioque R, Rodríguez-Conde MF, Reina-Ureña JV, et al. In vitro antioxidant and metal chelating properties of corm, tepal and leaf from saffron (Crocus sativus L.). Ind Crops Prod. 2012;39:149–153.
  • Sánchez-Vioque R, Santana-Méridas O, Polissiou M, et al. Polyphenol composition and in vitro antiproliferative effect of corm, tepal and leaf from Crocus sativus L. on human colon adenocarcinoma cells (Caco-2). J Funct Foods. 2016;24:18–25.
  • Hosseinzadeh H, Younesi HM Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002;2.
  • Fatehi M, Rashidabady T, Fatehi-Hassanabad Z Effects of Crocus sativus petals’ extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. J Ethnopharmacol. 2003;84:199–203.
  • Khorasany AR, Hosseinzadeh H Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: a review. Iran J Basic Med Sci. 2016;19:455–469.
  • Chang PY, Wang CK, Liang JD, et al. Studies on the pharmacological action of zang hong hua (Crocus sativus l.). I. Effects on uterus and estrus cycle. Yao Xue Xue Bao. 1964;11:94–100.
  • Grisolia S Hypoxia, saffron, and cardiovascular disease. Lancet. 1974;304:41–42.
  • Rezaee R, Hosseinzadeh H Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci. 2013;16:12–26.
  • Pfister S, Meyer P, Steck A, et al. Isolation and structure elucidation of carotenoid−glycosyl esters in gardenia fruits (Gardenia jasminoides Ellis) and saffron (Crocus sativus Linne). J Agric Food Chem. 1996;44:2612–2615.
  • Imenshahidi M, Razavi BM, Faal A, et al. The effect of chronic administration of safranal on systolic blood pressure in rats. Iran J Pharm Res. 2015;14:585–590.
  • Imenshahidi M, Razavi BM, Faal A, et al. Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats. Iran J Basic Med Sci. 2014;17:9–13.
  • Imenshahidi M, Razavi BM, Faal A, et al. The effect of chronic administration of saffron (Crocus sativus) stigma aqueous extract on systolic blood pressure in rats. Jundishapur J Nat Pharm Prod. 2013;8:175–179.
  • Mehdizadeh R, Parizadeh MR, Khooei AR, et al. Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iran J Basic Med Sci. 2013;16:56–63.
  • Imenshahidi M, Hosseinzadeh H, Javadpour Y Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res. 2010;24:990–994.
  • Ghasemi T, Abnous K, Vahdati F, et al. Antidepressant effect of Crocus sativus aqueous extract and its effect on CREB, BDNF, and VGF transcript and protein levels in rat hippocampus. Drug Res. 2015;65:337–343.
  • Vahdati Hassani F, Naseri V, Razavi BM, et al. Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. Daru. 2014;22.
  • Hosseinzadeh H, Karimi G, Niapoor M Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. J Med Plants. 2004;3:48–58.
  • Hosseinzadeh H, Jahanian Z Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res. 2010;24:726–730.
  • Mehri S, Abnous K, Khooei A, et al. Crocin reduced acrylamide-induced neurotoxicity in wistar rat through inhibition of oxidative stress. Iran J Basic Med Sci. 2015;18:902–908.
  • Rashedinia M, Lari P, Abnous K, et al. Protective effect of crocin on acrolein-induced tau phosphorylation in the rat brain. Acta Neurobiol Exp. 2015;75:208–219.
  • Tashakori-Sabzevar F, Hosseinzadeh H, Motamedshariaty VS, et al. Crocetin attenuates spatial learning dysfunction and hippocampal injury in a model of vascular dementia. Curr Neurovasc Res. 2013;10:325–334.
  • Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, et al. Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res. 2012;26:381–386.
  • Imenshahidi M, Zafari H, Hosseinzadeh H Effects of crocin on the acquisition and reinstatement of morphine-induced conditioned place preference in mice. Pharmacologyonline. 2011;1:1007–1013.
  • Hosseinzadeh H, Ziaei T Effects of Crocus sativus stigma extract and its constituents, crocin and safranal, on intact memory and scopolamine-induced learning deficits in rats performing the morris water maze task. J Med Plants. 2006;5:40-50+60.
  • Sadeghnia HR, Cortez MA, Liu D, et al. Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography. J Pharm Pharm Sci. 2008;11:1–14.
  • Hosseinzadeh H, Sadeghnia HR Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2007;14:256–262.
  • Hosseinzadeh H, Khosravan V Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Iran Med. 2002;5:44–47.
  • Hosseinzadeh H, Noraei NB Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009;23:768–774.
  • Amin B, Malekzadeh M, Heidari MR, et al. Effect of Crocus sativus extracts and its active constituent safranal on the harmaline-induced tremor in mice. Iran J Basic Med Sci. 2015;18:449–458.
  • Rastgoo M, Hosseinzadeh H, Alavizadeh H, et al. Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma. Planta Med. 2013;79:447–451.
  • Hosseinzadeh H, Sadeghnia HR, Ziaee T, et al. Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J Pharm Pharm Sci. 2005;8:387–393.
  • Hosseinzadeh H, Sadeghnia HR Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci. 2005;8:394–399.
  • Ghaeni FA, Amin B, Hariri AT, et al. Antilithiatic effects of crocin on ethylene glycol-induced lithiasis in rats. Urolithiasis. 2014;42:549–558.
  • Amin B, Hosseinzadeh H Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012;83:888–895.
  • Hosseinzadeh H, Shariaty VM Anti-nociceptive effect of safranal, a constituent of Crocus sativus (saffron), in mice. Pharmacologyonline. 2007;2:498–503.
  • Amin B, Abnous K, Motamedshariaty V, et al. Attenuation of oxidative stress, inflammation and apoptosis by ethanolic and aqueous extracts of Crocus sativus l. stigma after chronic constriction injury of rats. An Acad Bras Cienc. 2014;86:1821–1832.
  • Sahebari M, Mahmoudi Z, Rabe SZT, et al. Inhibitory effect of aqueous extract of Saffron (Crocus sativus L.) on adjuvant-induced arthritis in Wistar rat. Pharmacology Online. 2011;3:802–808.
  • Hosseinzadeh H, Abootorabi A, Sadeghnia HR Protective effect of Crocus sativus stigma extract and crocin (trans-crocin 4) on methyl methanesulfonate-induced DNA damage in mice organs. DNA Cell Biol. 2008;27:657–664.
  • Razavi BM, Hosseinzadeh H, Abnous K, et al. Protective effect of crocin against apoptosis induced by subchronic exposure of the rat vascular system to diazinon. Toxicol Ind Health. 2016;32:1237–1245.
  • Lari P, Abnous K, Imenshahidi M, et al. Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin. Toxicol Ind Health. 2015;31:367–376.
  • Razavi BM, Hosseinzadeh H, Imenshahidi M, et al. Evaluation of protein ubiquitylation in heart tissue of rats exposed to diazinon (an organophosphate insecticide) and crocin (an active saffron ingredient): role of HIF-1α. Drug Res. 2015;65:561–566.
  • Moallem SA, Hariri AT, Mahmoudi M, et al. Effect of aqueous extract of Crocus sativus L. (saffron) stigma against subacute effect of diazinon on specific biomarkers in rats. Toxicol Ind Health. 2014;30:141–146.
  • Razavi BM, Hosseinzadeh H, Abnous K, et al. Protective effect of crocin on diazinon induced vascular toxicity in subchronic exposure in rat aorta ex-vivo. Drug Chem Toxicol. 2014;37:378–383.
  • Razavi BM, Hosseinzadeh H, Movassaghi AR, et al. Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem-Biol Interact. 2013;203:547–555.
  • Hariri AT, Moallem SA, Mahmoudi M, et al. Sub-acute effects of diazinon on biochemical indices and specific biomarkers in rats: protective effects of crocin and safranal. Food Chem Toxicol. 2010;48:2803–2808.
  • Hariri AT, Moallem SA, Mahmoudi M, et al. The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine. 2011;18:499–504.
  • Ardebili Dorri S, Hosseinzadeh H, Abnous K, et al. Involvement of brain‐derived neurotrophic factor (BDNF) on malathion induced depressive‐like behavior in subacute exposure and protective effects of crocin. Iran J Basic Med Sci. 2015;18:958–966.
  • Mehri S, Abnous K, Mousavi SH, et al. Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32:227–235.
  • Amin B, Moghri Feriz H, Timcheh Hariri A, et al. Protective effects of the aqueous extract of Crocus sativus against ethylene glycol induced nephrolithiasis in rats. Excli J. 2015;14:411–422.
  • Razavi BM, Hosseinzadeh H Saffron as an antidote or a protective agent against natural or chemical toxicities. Daru. 2015;23:015–0112.
  • Golmohammadzadeh S, Jaafari MR, Hosseinzadeh H Does saffron have antisolar and moisturizing effects? Iran J Pharm Res. 2010;9:133–140.
  • Golmohammadzadeh S, Imani F, Hosseinzadeh H, et al. Preparation, characterization and evaluation of sun protective and moisturizing effects of nanoliposomes containing safranal. Iran J Basic Med Sci. 2011;14:521–533.
  • Hosseinzadeh H, Ziaee T, Sadeghi A The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine. 2008;15:491–495.
  • Mehrnia M-A, Jafari S-M, Makhmal-Zadeh BS, et al. Rheological and release properties of double nano-emulsions containing crocin prepared with Angum gum, Arabic gum and whey protein. Food Hydrocoll. 2017;66:259–267.
  • Faridi Esfanjani A, Jafari SM, Assadpour E Preparation of a multiple emulsion based on pectin-whey protein complex for encapsulation of saffron extract nanodroplets. Food Chem. 2017;221:1962–1969.
  • Mehrnia MA, Jafari SM, Makhmal-Zadeh BS, et al. Crocin loaded nano-emulsions: factors affecting emulsion properties in spontaneous emulsification. Int J Biol Macromol. 2016;84:261–267.
  • Khazaei KM, Jafari SM, Ghorbani M, et al. Optimization of anthocyanin extraction from saffron petals with response surface methodology. Food Anal Methods. 2016;9:1993–2001.
  • Jafari S-M, Mahdavi-Khazaei K, Hemmati-Kakhki A Microencapsulation of saffron petal anthocyanins with cress seed gum compared with Arabic gum through freeze drying. Carbohydr Polym. 2016;140:20–25.
  • Sarfarazi M, Jafari SM, Rajabzadeh G Extraction optimization of saffron nutraceuticals through response surface methodology. Food Anal Methods. 2015;8:2273–2285.
  • Rajabi H, Ghorbani M, Jafari SM, et al. Retention of saffron bioactive components by spray drying encapsulation using maltodextrin, gum Arabic and gelatin as wall materials. Food Hydrocoll. 2015;51:327–337.
  • Esfanjani AF, Jafari SM, Assadpoor E, et al. Nano-encapsulation of saffron extract through double-layered multiple emulsions of pectin and whey protein concentrate. J Food Eng. 2015;165:149–155.
  • Mahdavee Khazaei K, Jafari SM, Ghorbani M, et al. Application of maltodextrin and gum Arabic in microencapsulation of saffron petal’s anthocyanins and evaluating their storage stability and color. Carbohydr Polym. 2014;105:57–62.
  • Gainer JL, Grabiak RC, inventors; Diffusion Pharmaceuticals Llc., assignee. Bipolar trans carotenoid salts and their uses. European patent EP1667954 (A1). 2006 Jun 14.
  • Gainer JL, Lanz M, inventors; Diffusion Pharmaceuticals Llc., assignee. Trans carotenoids, their synthesis, formulation and uses. European patent EP2540696 (A1). 2013 Jan 2.
  • Gainer JL, inventor; Gainer JL, assignee. Trans-sodium crocetinate, methods of making and methods of use thereof. United States patent US6060511 (A). 2000 May 9.
  • Wang H, Li L, inventors; Weihai Novoda Pharmaceutical Group Co Ltd., assignee. Crocetin salt injection and preparation process thereof. Chinese patent CN104434785 (A). 2015 Mar 25.
  • Gainer JL, inventor; Diffusion Pharmaceuticals Llc., assignee. Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease. United States patent US2008255246 (A1). 2008 Oct 16.
  • Gainer JL, inventor; Diffusion Pharmaceuticals Llc., assignee. Class of therapeutics that enhance small molecule diffusion. United States patent US8206751 (B2). 2012 Jun 26.
  • Gainer JL, Murray R, inventors; Diffusion Pharmaceuticals Llc., assignee. Oral formulations of bipolar trans carotenoids. United States patent US2015352068 (A1). 2015 Dec 10.
  • Gainer JL, inventor; Diffusion Pharmaceuticals Llc., assignee. Diffusion enhancing compounds and their use alone or with thrombolytics. United States patent US2010322918 (A1). 2010 Dec 23.
  • Lockwood SF, O’Malley S, Watumull DG, et al., inventors; Cardax Pharmaceuticals Inc., assignee. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease. United States patent US7723327 (B2). 2010 May 25.
  • Lockwood S, O’Malley S, Watumull D, et al., inventors; Lockwood SF, O’malley S, Watumull DG, Hix LM, Jackson H, Nadolski G, assignee. Carotenoid ester analogs or derivatives for controlling connexin 43 expression. United States patent US2005009788 (A1). 2005 Jan 13.
  • Lockwood S, O’Malley S, Watumull D, et al., inventors; Lockwood SF, O’malley S, Watumull DG, Hix LM, Jackson H, Nadolski G, assignee. Carotenoid ether analogs or derivatives for controlling C-reactive protein levels. United States patent US2005049248 (A1). 2005 Mar 3.
  • Wu N, inventor; Wu N, assignee. Polymer-carbohydrate conjugates for drug delivery technology. United States patent US2015157721 (A1). 2015 Jun 11.
  • Idelevich P, Elkeles A, Terkieltaub D, et al., inventors; Zetiq Technologies Ltd., assignee. Methods and kits for differential staining of abnormal urinary system cells. United States patent US2013266960 (A1). 2013 Oct 10.
  • Gelvan DJ, Goltsman L, Chausovsky A, inventors; Zetiq Tech Ltd, Gelvan DJ, Goltsman L, Chausovsky A, assignee. Methods and compositions for identifying a cell phenotype. United States patent US8343733 (B2). 2013 Jan 1.
  • Dhar A, Gutheil WG, inventors; Dhar A, Gutheil WG, US Dept Veterans Affairs, Univ Missouri, Univ Kansas., assignee. In Vivo method for treating, inhibiting, and/or prophylaxis of cancer, such as pancreatic cancer. United States patent US2014221491 (A1). 2014 Aug 7.
  • Petyaev I, inventor; Petyaev I, IP Science Ltd., assignee. Carotenoid particles and uses thereof. United States patent US2013337068 (A1). 2013 Dec 19.
  • Piergallini R, Loupis N, Jaworska J, et al., inventors; Klox Technologies Inc., assignee. Biophotonic hydrogels. World Intellectual Property Organization patent WO2015184551 (A1). 2015 Dec 10.
  • Piergallini R, Loupis N, Devemy E, et al., inventors; Klox Technologies Inc., assignee. Thermosetting biophotonic compositions and uses thereof. World Intellectual Property Organization patent WO2015188271 (A1). 2015 Dec 17.
  • Loupis N, Piergallini R, Rastogi S, inventors; Klox Technologies Inc., assignee. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds United States patent US2016193338 (A1). 2016 Jul 7.
  • Desrosiers E, Loupis N, Piergallini R, inventors; Klox Technologies Inc., assignee. Biophotonic materials and uses thereof. Canadian patent CA2902363 (A1). 2014 Sep 18.
  • Loupis N, Piergallini R, inventors; Klox Technologies Inc., assignee. Compositions and methods for biophotonic bone reconstruction. United States patent US2015119789 (A1). 2015 Apr 30.
  • Loupis N, Piergallini R, Rastogi S, inventors; Klox Technologies Inc., assignee. Biophotonic compositions, kits and methods. United States patent US2015119788 (A1). 2015 Apr 30.
  • Piergallini R, Loupis N, Bellini F, inventors; Klox Technologies Inc., assignee. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin. European patent EP 2352488 (A1). 2011 Aug 10.
  • Piergallini R, Loupis N, inventors; Piergallini R, Loupis N, Klox Technologies Inc., assignee. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease. United States patent US8685466 (B2). 2014 Apr 1.
  • Piergallini R, Loupis N, Bellini F, inventors; KLOX Technologies Inc., assignee. Method for acne treatment using an oxidative-photoactivated composition. United States patent US8911791 (B2). 2014 Dec 16.
  • Piergallini R, Loupis N, Bellini F, inventors; Klox Technologies Inc., assignee. Combination of an oxidant and a photoactivator for the healing of wounds. World Intellectual Property Organization patent WO2010051636 (A1). 2010 May 14.
  • Urade Y, Huang Z-L, Aritake K, et al., inventors; Osaka Bioscience Inst, Urade Y, Huang Z-L, Aritake K, Higashi T, Matsumoto N, Masaki M, Shoyama Y, Tanaka H, Du X-M, assignee. Sleep-improving agent, sedative agent, and use thereof. Japanese patent WO2010061574 (A1). 2010 Jun 3.
  • Huang Z, Zatoide Y, Qu W, inventors; Fudan University., assignee. Application of crocin in preparing hypnotic drug. Chinese patent CN101791314 (A). 2010 Aug 4.
  • Thomaoglou C, inventor; Thomaoglou C, assignee. Edible composition including safranal, crocin, picrocrocin and a vitamin B complex for treating the initial phase of depression. French patent WO2015124318 (A1). 2015 Aug 27.
  • Tao W, Chen G, inventors; Nanjing University of Chinese Medicine., assignee. Refined part of total gardenia crocin with anti-depression effect as well as preparation method and application of refined part. Chinese patent CN104491075 (A). 2015 Apr 8.
  • Tian J, Fu F, Liu K, et al., inventors; Shandong Greenery Natural Medicine Research & Development Co., Ltd., assignee. Application of crocin-A in brain protection. Chinese patent CN1827097 (A). 2006 Sep 6.
  • Zhang Z, inventor; Zhang Z, assignee. Natural ingredient for promoting spermatogenesis and composition thereof. Chinese patent CN104177249 (A). 2014 Dec 3.
  • Lamy L, inventor; Givaudan Sa., assignee. Use of crocin for reducing wrinkles. French patent WO2015150378 (A1). 2015 Nov 8.
  • He J, Liu L, Duan L, et al., inventors; Wuhan New Guofeng Technology Dev Co Ltd., assignee. Nature crocin extraction separation method and preparation for crocin blood fat reduction drug. Chinese patent CN103665059 (A). 2014 Mar 26.
  • Bourges C, inventor; Bourges C, assignee. Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity. United States patent US20100028464. 2010 Feb 4.
  • Mikulásik E, Spaits T, Sinka ÁS, inventors; Egis Pharmaceuticals Plc., assignee. Transdermal formulation containing cox inhibitors. United States patent US2015231247 (A1). 2015 Aug 20.
  • Kondo T, inventor; Sunsho Pharmaceutical Co., Ltd., assignee. Disintegrable capsule, manufacturing method for same, and smoking equipment containing said disintegrable capsule. United States patent US2016021927 (A1). 2016 Jan 28.
  • Hearn A, Gupta R, Bowdrey M, inventors; Kind Consumer Ltd., assignee. Cannabinoid inhaler and composition therefor. United States patent US20150231108 (A1). 2015 Aug 20.
  • Hearn A, Lowe SB, Gupta R, et al., inventors; Kind consumer Ltd., assignee. Nicotine composition. United States patent US2015297580 (A1). 2015 Oct 22.
  • Singh IP, Mahajan S Berberine and its derivatives: a patent review (2009 – 2012). Expert Opin Ther Pat. 2013;23:215–231.
  • Wang J, inventor; Wang J, assignee. Traditional Chinese medicine for treating globus hysteriocus. Chinese patent CN104721706 (A). 2015 Jun 24.
  • Bin C, Qingtao X, inventors; Zibo development zone yada pharmaceutical Co., Ltd., assignee. Depression treating traditional Chinese medicine. Chinese patent CN104706921. 2015 Jun 17.
  • Yu Q, inventor; Qiaoyuan Y, assignee. Traditional Chinese medicine composition for treating meridian obstruction type cerebral arteriosclerosis. Chinese patent CN104623449 (A). 2015 May 20.
  • Zhang Q, Liu Q, inventors; Zhang Q, assignee. Heart-nourishing capsules for treating coronary heart disease. Chinese patent CN1939483 (A). 2007 Apr 4.
  • Xiuxiang Z, Shunhou Z, inventors; Xiuxiang Z, assignee. Medicine for treating coronary heart disease. Chinese patent CN101612349 (A). 2009 Dec 30.
  • Xiangming H, Yong H, inventors; Huang X, assignee. Traditional Chinese medicinal preparation for treating coronary heart disease and preparation method thereof. Chinese patent CN101695538 (A). 2010 Apr 21.
  • Sun F, inventor; Sun F, assignee. Traditional Chinese medicine composition for treating coronary heart disease. Chinese patent CN103505614 (A). 2014 Jan 15.
  • Shengsang N, Su RZ, Mei H, et al. Inventors; Inner Mongolia Medical University., assignee. Compound Mongolian medicine preparation for treating coronary heart disease. Chinese patent CN103142923 (B). 2015 Jan 12.
  • Ren T, inventor; Ren T, assignee. Specific medicine for treating coronary disease. Chinese patent CN102600342 (B). 2013 Oct 2.
  • Kaiser AH, Yang X, Muhe TBB, et al. Inventors; College Of Xinjiang Uyghur Medicine., assignee. Aiweixin oral solution for treating cardiovascular diseases and preparation method thereof. Chinese patent CN104042797 (A). 2014 Sep 17.
  • Sun FS, Tang Z, Chen D, et al., inventors; Sun FU, assignee. Medicine for treating heart failure. Chinese patent CN101057934 (A). 2007 Oct 24.
  • Qian J, inventor; Jinan Shunjing Pharmaceutical Technology Co., Ltd., assignee. Medicine for treating angina pectoris of coronary atherosclerotic heart disease. Chinese patent CN104352775 (A). 2015 Feb 18.
  • Nimaciren, inventor; Nimaciren., assignee. Tibetan medicine composite for treating diabetes and preparation method of preparation thereof. Chinese patent CN101700397 (A). 2010 May 5.
  • Qi ZQ, Qi Z, Qi L, et al., inventors; Zhengixn QI, assignee. External-use Chinese medicine preparation for treating periphery angiopathy. Chinese patent CN1814095 (A). 2006 Aug 9.
  • Wang Y, Wang L, Pang R, inventors; Wang Y, assignee. Traditional Chinese medicine decoction for treating angiitis. Chinese patent CN104491155 (A). 2015 Apr 8.
  • Huang Y, inventor; Qingdao Xiangjia Intellectual Property Service Co Ltd., assignee. Health wine for lowering lipid and stabilizing blood pressure. Chinese patent CN104988002 (A). 2015 Oct 21.
  • Zhanming J, inventor; Zhanming J, assignee. Traditional Chinese medicine for effectively treating cardiovascular and cerebrovascular diseases and preparation method thereof. Chinese patent CN104721680 (A). 2015 Jun 24.
  • Chen W, inventor; Chen W, assignee. Gingko essence oral liquid and preparation method thereof. Chinese patent CN104413494 (A). 2015 Mar 18.
  • Zhang S, inventor; Zhang S, assignee. Medicine for treating bone injures and preparing method. Chinese patent CN1814106 (A). 2006 Aug 9.
  • Zhang L, inventor; Suwin Shandong Pharmaceutical Co Ltd., assignee. Medicinal liquor for treating ankylosing spondylitis, and processing method thereof. Chinese patent CN103690696 (A). 2014 Apr 2.
  • Baiyun JE, inventor; Baiyun JE, assignee. Compound sweet wormwood Mongolian medicine insufflation. Chinese patent CN1303706 (A). 2001 Jul 18.
  • Peng C, Zhang L, inventors; Chengdu Huaxi Technology Co Ltd., assignee. Saffron-containing traditional Chinese medicinal composition for enhancing immunity. Chinese patent CN104474259 (A). 2015 Apr 1.
  • Liu X, inventor; Liu X, assignee. Externally-applied wet tissue for treating measles and preparation method thereof. Chinese patent CN104435413 (A). 2015 Mar 25.
  • Wang X, Zhao Z, inventors; Zhao Z, assignee. Drug for nursing and treating herpes zoster and preparation method of drug. China patent CN104784496 (A). 2015 Jul 22.
  • Chen Y, Lu X, Zhang H, et al., inventors; First Affiliated Hospital Nanjing Medical Univ., assignee. Traditional Chinese medicine composition for treating septic shock and accompanying multi-organ dysfunction syndrome. Chinese patent CN104435669 (A). 2015 Mar 25.
  • Zheng J, inventor; Zheng J, assignee. Traditional Chinese medicine preparation for treating pediatric acute otitis media. Chinese patent CN104056029 (A). 2014 Sep 24.
  • Ji X, Sun YN, Zhang L, et al., inventors; Ji X, assignee. Chinese herbal medicine formula for treating nasopharyngitis and preparation method thereof. Chinese patent CN103784753 (A). 2014 May 14.
  • Liu X, inventor; Liu X, assignee. Traditional Chinese medicine composition for treating rupture-stage lung abscess. Chinese patent CN104474333 (A). 2015 Apr 1.
  • Liu X, inventor; Liu X, assignee. Traditional Chinese medicine composition for treating pulmonary abscess at abscess formation stage. Chinese patent CN104435809 (A). 2015 Mar 25.
  • Lei C, Lei S, Mai Y, inventors; Changzhou yahuan environmental protection technology Co., Ltd., assignee. Chinese patent drug for treating syphilis and preparation method thereof. Chinese patent CN102631552 (A). 2012 Aug 15.
  • Shi S, Ma Z, inventors; Qingdao Boyanda Ind Technology Res., assignee. Traditional Chinese medicine for treating chest stuffiness and pains with syndrome of yang deficiency and cold congelation and preparation method thereof. Chinese patent CN104547844 (A). 2015 Apr 29.
  • Cui H, inventor; Cui H, assignee. Traditional Chinese medicine preparation for treating cataract and preparation. Chinese patent CN104383465 (A). 2015 Mar 4.
  • Huang R, Huang X, inventors; Huang R, Guangxi Jinchuangucao Biological Science & Technology Co., Ltd., assignee. Chinese medicinal composition for the treatment of gout and its preparation method. Chinese patent CN103690699 (B). 2016 Feb 17.
  • Huang J, inventor; Huang J, assignee. Traditional Chinese medicine preparation for treating rheumatic heart disease. Chinese patent CN104352890 (A). 2015 Feb 18.
  • Zhao H, Shan X, Shan Y, inventors; Zhao H, assignee. Pain relieving plaster. Chinese patent CN103550675 (A). 2014 Feb 5.
  • Ren L, inventor; Beijing Jianxun Medical Technology Co Ltd., assignee. Traditional Chinese medicine for external use for treating back pain and lumbar disc hemiation. Chinese patent CN104435550 (A). 2015 Mar 25.
  • Ruiling S, inventor; Ruiling S, assignee. Blood-circulation and removing blood stasis ointment. Chinese patent CN101164610 (A). 2008 Apr 23.
  • Huang R, inventor; Rong H, Guangxi Liuzhou Jinchuangucao Biotechnology Co Ltd., assignee. Chinese medicine for treating ankylosing apondylitis and preparation method thereof. Chinese patent CN102579710 (B). 2013 Sep 25.
  • Miao E, inventor; Miao E, assignee. Traditional Chinese medicine for treating rheumatic arthritis and preparation method thereof. Chinese patent CN104288741 (A). 2015 Apr 21.
  • Sun L, inventor; Yantai ruizhi biomedical technology Co Ltd., assignee. Traditional Chinese medicine capable of treating qi stagnation and blood stasis amenorrhea. Chinese patent CN104042822 (A). 2014 Sep 17.
  • Wang T, inventor; Wang T, assignee. Tibetan bee venom plaster for treating bone diseases. Chinese patent CN103751446 (A). 2014 Apr 30.
  • Zhang Y, Liang F, Lin X, inventors; Zhang Y, assignee. Cataplasm for treating lumbar interveterbral disc protrusion. Chinese patent CN104666681 (A). 2015 Jun 3.
  • Jintao H, Jinshuai H, Shichang H, inventors; Shichang H, assignee. Chinese medicinal composition for treating osteoproliferation and herniated disk and preparation method thereof. Chinese patent CN101947291 (B). 2012 May 30.
  • Wang F, inventor; Wang F, assignee. Traditional Chinese medicine for treating cervical spondylosis. Chinese patent CN103550716 (A). 2014 Feb 5.
  • Sheng S, inventor; Wuwei County Dougou Town Central Health Center., assignee. Traditional Chinese medicinal decoction for treating prostatic hyperplasia caused by kidney qi deficiency. Chinese patent CN102743525 (A). 2012 Oct 24.
  • Lin H, inventor; Lin H, assignee. Healthcare oil for treating gynecologic diseases and preparation method thereof. Chinese patent CN103751470 (A). 2014 Apr 30.
  • Li H, inventor; Li H, assignee. Traditional Chinese medicine for treating dysmenorrhea and preparation method of traditional Chinese medicine. Chinese patent CN103768536 (A). 2014 May 7.
  • Liu M, inventor; Liu M, assignee. Chinese medicinal composition for treating dysmenorrhea and preparation method of same. Chinese patent CN102526415 (B). 2013 Sep 11.
  • Shixian D, inventor; Shixian D, assignee. Medicine for treating dysmenorrheal and preparation method thereof. Chinese patent CN102764399 (A). 2012 Nov 7.
  • Zhang Z, inventor; Jinan Fangyu Culture Media Co Ltd., assignee. Navel paste for treating dysmenorrheal and preparation method thereof. Chinese patent CN104922631. 2015 Sep 23.
  • Yu Y, inventor; Yu Y, assignee. Traditional Chinese medicine for treating dysfunction of endocrine. Chinese patent CN104940885 (A). 2015 Sep 30.
  • Sun P, Wei J, Li J, et al., inventors; Qingdao Central Hospital., assignee. Formula of traditional Chinese medicine for treating premature ovarian failure. Chinese patent CN104587188 (A). 2015 May 6.
  • Zhang H, inventor; Zhang H, assignee. Traditional Chinese medicine composition for treating hypofunction of ovary and preparation method of composition. Chinese patent CN103948794 (A). 2014 Jul 30.
  • Tao E, inventor; Univ Weifang Medical., assignee. Traditional Chinese medicine for treating blocking-antibody-deficiency type recurrent spontaneous abortion. Chinese patent CN104645030 (A). 2015 May 27.
  • Sun P, Wei J, Li J, et al., inventors; Qingdao Central Hospital., assignee. Traditional Chinese medicine formula for treating chronic pelvic inflammation. Chinese patent CN104587400 (A). 2015 May 6.
  • Liu W, inventor; Liu W, assignee. Traditional Chinese medicine for treating qi stagnation type abdominal mass. Chinese patent CN104306575 (A). 2015 Jan 28.
  • Chang K, inventor; Chang K, assignee. Drug for treating uterus myoma. Chinese patent CN104623239 (A). 2015 May 20.
  • Zhang D, Liu H, inventors; Zhang D, assignee. Traditional Chinese medicine composition for treating postpartum agalactia, and preparation method thereof. Chinese patent CN104940870 (A). 2015 Sep 30.
  • Song J, inventor; Song J, assignee. Traditional Chinese medicine composition for treating infertility caused by cold uterus. Chinese patent CN103948883 (A). 2014 Aug 30.
  • Yang C, inventor; Yang C, assignee. Traditional Chinese medicine composition capable of improving immunity and resisting fatigue. Chinese patent CN102631487 (B). 2013 Aug 14.
  • Cuihong Y, inventor; Cuihong Y, assignee. Health care composition. Chinese patent CN102631497 (A). 2012 Aug 15.
  • Piraee M, inventor; Persavita Ltd., assignee. Composition comprising resveratrol and saffron. United Kingdom patent GB2483121 (A). 2012 Feb 29.
  • Bisti S, Sernagor E, inventors; Hortus Novus Srl., assignee. Compositions based on saffron for the prevention and/or treatment of corneal dystrophies. World Intellectual Property Organization patent WO2016042528. 2016 Mar 24.
  • Liao D, inventor; Liao D, assignee. Tai chi oil and preparation method thereof. Chinese patent CN102805785 (B). 2012 Dec 5.
  • Shen H, inventor; Shen H, assignee. Moisture-preserving and skin-tendering cosmetic prepared from natural plant ingredients and preparation method of moisture-preserving and skin-tendering cosmetic. Chinese patent CN104173268 (A). 2014 Dec 3.
  • Xia J, inventor; Xia J, assignee. Anti-inflammatory, antalgic and scar-suppressive traditional Chinese medicinal ointment. Chinese patent CN103446507 (A). 2013 Dec 18.
  • Wu H, Wu M, inventors; Jinan Zhenya Cosmetics Co Ltd., assignee. Nine-herb cream with effects of whitening and removing freckle marks and preparation method thereof. Chinese patent CN104434618 (A). 2015 Mar 25.
  • Wang P, inventor; Baoding Huaren Vitiligo Hospital., assignee. Traditional Chinese medicine ointment used for treating leucoderma, and preparation method thereof. Chinese patent CN103505574 (A). 2014 Jan 15.
  • Wang X, inventor; Wang X, assignee. Traditional Chinese medicine composition for treating leucoderma. Chinese patent CN104547321 (A). 2015 Apr 29.
  • Jin H, Wang Y, Wang L, et al., inventors; Qingdao Municipal Hospital., assignee. Traditional Chinese medicine ointment for treating scleroderma and preparation method of traditional Chinese medicine ointment. Chinese patent CN104606399 (A). 2015 May 13.
  • Cui H, inventor; Cui H, assignee. Medicine for treating eyelid eczema and application thereof. Chinese patent CN104491311 (A). 2015 Apr 8.
  • Zhao N, inventor; Zhao N, assignee. Saffron liquid. Chinese patent CN102078455 (A). 2011 Jun 1.
  • Tong S, inventor; Tong S, assignee. Traditional Chinese medicine for treating acne. Chinese patent CN102793808 (A). 2012 Nov 28.
  • Wang L, inventor; Wang L, assignee. Hairdressing fluid for treating acnes. Chinese patent CN104645022 (A). 2015 Mar 27.
  • Chen Y, Wang C, inventors; Wang C, assignee. Traditional Chinese medicine for treating lung tumour and preparation method thereof. Chinese patent CN104013792 (A). 2014 Sep 3.
  • Zhang Q, inventor; Zhang Q, assignee. Drug for treating breast cancer and preparation method thereof. Chinese patent CN104288489 (A). 2015 Jan 21.
  • Sun L, inventor; Yantai Ruizhi Biolog Medicine Science and Technology Co Ltd., assignee. Traditional Chinese medicine for treating damp-heat stagnation type abdominal mass. Chinese patent CN104208332 (A). 2014 Dec 17.
  • Xie M, inventor; Xie M, assignee. Medicinal and edible dual-purpose health care product for protecting chemical liver damage and preparation method thereof. Chinese patent CN103392960 (A). 2013 Nov 20.
  • Li G, inventor; Cui H, assignee. Traditional Chinese medicine composition for clinically nursing and treating ascites due to cirrhosis. Chinese patent CN104758829 (A). 2015 Aug 8.
  • Miao E, inventor; Miao E, assignee. Traditional Chinese medicine composition for treating duodenal ulcer and preparation method thereof. Chinese patent CN104288663 (A). 2015 Jan 21.
  • Wang S, inventor; Wang S, assignee. A traditional Chinese medicine for treating nonulcer dyspepsia. Chinese patent CN104667138 (A). 2015 May 3.
  • Zhang D, Hao X, Xue L, inventors; Zhang D, assignee. Traditional Chinese medicinal preparation for treating peptic ulcer and method for preparing preparation. Chinese patent CN104547542 (A). 2015 Apr 29.
  • Li M, inventor; Li M, assignee. Traditional Chinese medicine composition for treating stasis stomach impairing type chronic gastritis. Chinese patent CN104906275 (A). 2015 Sep 16.
  • mentioned Tihwtrtb, inventor; Qingdao Huaren Technology Incubator Co., Ltd., assignee. Medicinal preparation used for treating chloasma. Chinese patent CN104042944 (A). 2014 Sep 17.
  • Liu D, inventor; Liu D, assignee. Traditional chinese medicine for protecting liver and gallbladder and preparing method thereof. Chinese patent CN103816306 (A). 2014 May 28.
  • Cook-Deegan R, Niehaus A After myriad: genetic testing in the wake of recent supreme court decisions about gene patents. Curr Genet Med Rep. 2014;2:223–241.
  • Hefferon K Plant biotechnology patents: applications in agriculture and medicine. Recent Pat Biotechnol. 2010;4:136–152.
  • Bostan HB, Mehri S, Hosseinzadeh H Toxicology effects of saffron and its constituents: a review. Iran J Basic Med Sci. 2017;20:110–121.
  • Razavi BM, Hosseinzadeh H Saffron: a promising natural medicine in the treatment of metabolic syndrome. J Sci Food Agric. 2017;97:1679–1685.
  • Hosseinzadeh H Saffron: a herbal medicine of third millennium. Jundishapur J Nat Pharm Prod. 2014;9:1–2.
  • Moshiri M, Vahabzadeh M, Hosseinzadeh H Clinical applications of saffron (Crocus sativus) and its constituents: a review. Drug Res. 2015;65:287–295.
  • Bone K, Mills S Principles and practice of phytotherapy modern herbal medicine. Edinburgh (UK): Churchill livingstone 2013.
  • Ziaee T, Razavi BM, Hosseinzadeh H Saffron reduced toxic effects of its constituent, safranal, in acute and subacute toxicities in rats. Jundishapur J Nat Pharm Prod. 2014;9:3–8.
  • Hosseinzadeh H, Shakib SS, Sameni AK, et al. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats. Iran J Pharm Res. 2013;12:93–99.
  • Moallem SA, Afshar M, Etemad L, et al. Evaluation of teratogenic effects of crocin and safranal, active ingredients of saffron, in mice. Toxicol Ind Health. 2016;32:285–291.
  • Modaghegh MH, Shahabian M, Esmaeili HA, et al. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008;15:1032–1037.
  • Mohamadpour AH, Ayati Z, Parizadeh MR, et al. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci. 2013;16:39–46.
  • Lautenschlager M, Sendker J, Huwel S, et al. Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier. Phytomedicine. 2015;22:36–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.